Breathe Easier, Live Better: How RAVCARE COPD Can Empower You

Chronic obstructive pulmonary disease (COPD) is a serious lung condition affecting millions worldwide. While millions struggle with it, a staggering 70% remain undiagnosed. This makes early intervention and proper management crucial.

The Challenge: Getting Diagnosed and Staying on Top of COPD

Traditionally, diagnosing COPD relies on pulmonary function tests (PFTs). These tests are important, but scheduling them can be inconvenient. Even then, interpreting PFT results can be complex.

RAVCARE’s Secret Weapon: AI for Accurate Diagnosis and Beyond

RAVCARE COPD Digital Therapeutics steps in with a revolutionary approach. Our AI software analyzes PFT results with unmatched accuracy, exceeding even the combined expertise of multiple pulmonologists. This means faster, more reliable diagnoses, putting you on the path to better management sooner.

Revolutionizing Health by Reclaiming Cardiometabolic Well-being.

Empowering people to take control of their chronic conditions through personalized digital therapeutics.

Eon uses the most advanced form of AI to create layered Computational Linguistics (CL) data science models. CL understands text and the linguistic structure of English, similar to how the human brain reads. EPM eliminates the noise by extracting clinically relevant information from radiology reports, saves FTE time, and improves patient outcomes.

EPM is the first and only solution to identify incidental pulmonary nodules on Magnetic Resonance (MR), X-Ray, and Computed Tomography (CT) reports. This allows facilities to capture approximately 25% more incidental pulmonary nodules.

Eon is a digital health company that has created the industry's first Intelligent Care platform. Our advanced AI integrates with your EHR to identify incidental findings with 98% accuracy. From there, our technology risk-stratifies patients, creates custom care plans, and automates patient/provider outreach to increase adherence and outcomes.

The company now works with more than 1,000 hospitals, and has impacted more than 1.5 million patients.

• Robust computational linguistics models
• Care management support to offload nodule management to Eon teams
• Accuracy of nodule identification, and automation of next steps

• 1,000+ hospital and radiology center partners
• 414 million radiology scans analyzed since 2021
• 15.7 million abnormalities identified since 2021